Walvax Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Market Capitalization	20,536	17,449	19,320	37,601	64,274	89,423
Market Cap Growth	27.51%	-9.69%	-48.62%	-41.50%	-28.12%	50.25%
Enterprise Value	21,333	17,300	18,563	36,117	62,959	88,584
Last Close Price	12.84	10.77	11.92	23.17	39.60	55.35
PE Ratio	72.36	98.17	135.90	89.66	88.21	209.06
Forward PE	68.48	83.34	83.34	83.34	83.34	83.34
PS Ratio	8.56	7.22	6.85	9.14	12.64	25.82
PB Ratio	2.63	1.83	1.68	3.30	5.85	8.94
P/TBV Ratio	3.13	2.25	2.31	4.57	8.15	11.16
P/FCF Ratio	208.75	-	39.71	199.74	582.65	-
P/OCF Ratio	32.47	35.54	18.64	33.16	53.50	126.79
EV/Sales Ratio	8.89	7.15	6.58	8.78	12.38	25.58
EV/EBITDA Ratio	33.51	35.63	47.89	32.22	44.27	95.49
EV/EBIT Ratio	88.83	165.82	773.04	43.46	53.63	111.82
EV/FCF Ratio	216.86	-	38.16	191.86	570.72	-
Debt / Equity Ratio	0.17	0.04	0.04	0.07	0.04	0.03
Debt / EBITDA Ratio	2.14	0.78	1.19	0.70	0.32	0.34
Debt / FCF Ratio	13.86	-	1.01	4.28	4.19	-
Net Debt / Equity Ratio	0.05	-0.13	-0.28	-0.31	-0.31	-0.31
Net Debt / EBITDA Ratio	0.63	-2.63	-8.44	-3.17	-2.40	-3.37
Net Debt / FCF Ratio	3.99	68.53	-6.72	-18.90	-30.92	7.85
Asset Turnover	0.19	0.18	0.19	0.27	0.35	0.30
Inventory Turnover	1.01	0.95	0.83	0.74	0.72	0.60
Quick Ratio	1.67	2.01	2.63	2.37	2.24	2.07
Current Ratio	2.16	2.35	2.98	2.73	2.55	2.37
Return on Equity (ROE)	2.69%	1.19%	1.52%	4.57%	8.94%	6.74%
Return on Assets (ROA)	1.18%	0.49%	0.10%	3.36%	5.06%	4.25%
Return on Invested Capital (ROIC)	2.44%	0.95%	0.28%	9.20%	14.24%	10.50%
Return on Capital Employed (ROCE)	2.60%	1.00%	0.20%	6.70%	9.90%	7.60%
Earnings Yield	1.39%	1.02%	0.74%	1.11%	1.13%	0.48%
FCF Yield	0.48%	-0.11%	2.52%	0.50%	0.17%	-0.45%
Dividend Yield	1.33%	1.44%	0.08%	0.04%	0.03%	0.05%
Payout Ratio	293.96%	444.39%	28.80%	4.76%	6.88%	19.48%
Buyback Yield / Dilution	-1.49%	-0.05%	0.06%	0.21%	-1.93%	-0.90%
Total Shareholder Return	-0.16%	1.39%	0.15%	0.26%	-1.91%	-0.85%